---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003909"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2025-01-28T23:59:59+00:00"
generated_at: "2026-05-27T08:34:16.483909+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Telomir-1 fully reverses oxidative stress in human cells; explores bird flu treatment

## Summary
- Telomir-1 fully normalized ROS levels in human cell lines, reversing copper-induced oxidative stress.
- Provided strong cellular protection against copper toxicity while maintaining cell integrity.
- Effective at doses significantly lower than copper levels, indicating unique regulatory mechanism.
- Company evaluating Telomir-1 as potential treatment for avian influenza (bird flu) and other viruses.

## SEC filing metadata
- accession: 0001493152-25-003909
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2025-01-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000149315225003909/0001493152-25-003909-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000149315225003909/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003909
- JSON: https://secwatch.observer/filing/0001493152-25-003909.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003909.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.